Page last updated: 2024-09-02

ci 988 and Carcinoma, Anaplastic

ci 988 has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Howes, LG; Morris, DL; Romani, R	1

Other Studies

1 other study(ies) available for ci 988 and Carcinoma, Anaplastic

Article	Year
Dose dependent in vivo inhibition of human colorectal cancer (LoVo) by the gastrin receptor antagonist, CI-988. Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:5 Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Division; Colorectal Neoplasms; Dose-Response Relationship, Drug; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Cholecystokinin; Tumor Cells, Cultured	1996

Article

Year

Dose dependent in vivo inhibition of human colorectal cancer (LoVo) by the gastrin receptor antagonist, CI-988.

Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:5

Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Division; Colorectal Neoplasms; Dose-Response Relationship, Drug; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Cholecystokinin; Tumor Cells, Cultured

1996